Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05673070 · ClinicalTrials.gov registry record · NA

Use of Ritual Prenatal Multivitamins for Pregnancy

A NA study, sponsored by City University of New York.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT05673070 is a NA study that has completed, run by City University of New York. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05673070, a NA study, has completed, sponsored by City University of New York.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Prenatal multivitamin/multimineral supplements (MVI) provide important nutrition supplement to the diet of pregnant women to cover potential deficiencies and optimize nutrition status of both mom and baby, especially when the diet is suboptimal or nutrient demand is high while absorption is hindered by various factors such as genetic variance and gastrointestinal function. In this double-blind, randomized, controlled trial, the investigators will recruit 70 pregnant women at gestational week 12-14 and randomly assign them to either receive a Ritual prenatal MVI (n=40) or another commercially available prenatal MVI (n=40) through out pregnancy. Both supplements are over the counter and commercially available. The major differences between the two MVIs are the chemical form of folate as either 5-methyl-tetrahydrofolate or folic acid, and the dosages of vitamin D, biotin, and docosahexaenoic acid. The investigators will collect blood samples in each trimester of pregnancy and the placenta and cord blood at delivery to assess differences in blood nutrient levels. The investigators hypothesize that consumption of Ritual MVI leads to better nutrition status and biomarkers in maternal-fetal dyads compared to control during the antepartum period.

Interventions

  • DIETARY_SUPPLEMENT Ritual Epre Multivitamin-mineral supplement
  • DIETARY_SUPPLEMENT control MVI

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-10-15
Est. Completion 2024-12-31
Phase NA

Sponsor

City University of New York

9 total trials

What the Registry Record Tells You About NCT05673070

The ClinicalTrials.gov registry entry for NCT05673070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City University of New York, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ritual Epre Multivitamin-mineral supplement is the first listed.

NCT05673070 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05673070 about?

NCT05673070 is a clinical study titled "Use of Ritual Prenatal Multivitamins for Pregnancy". Prenatal multivitamin/multimineral supplements (MVI) provide important nutrition supplement to the diet of pregnant women to cover potential deficiencies and optimize nutrition status of both mom and baby, especially when the diet is suboptimal or nutrient demand is high while absorption is hindered...

What is the current status of trial NCT05673070?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-10-15. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT05673070?

The interventions under investigation include: Ritual Epre Multivitamin-mineral supplement (DIETARY_SUPPLEMENT), control MVI (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05673070?

This trial is sponsored by City University of New York, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.